Literature DB >> 25527087

Production of CNT-taxol-embedded PCL microspheres using an ammonium-based room temperature ionic liquid: as a sustained drug delivery system.

Seong Yeol Kim1, Ji-Young Hwang2, Jae-Won Seo1, Ueon Sang Shin3.   

Abstract

We describe a one-pot method for the mass production of polymeric microspheres containing water-soluble carbon-nanotube (w-CNT)-taxol complexes using an ammonium-based room temperature ionic liquid. Polycaprolactone (PCL), trioctylmethylammonium chloride (TOMAC; liquid state from -20 to 240°C), and taxol were used, respectively, as a model polymer, room temperature ionic liquid, and drug. Large quantities of white colored PCL powder without w-CNT-taxol complexes and gray colored PCL powders containing w-CNT-taxol (1:1 or 1:2 wt/wt) complexes were produced by phase separation between the hydrophilic TOMAC and the hydrophobic PCL. Both microsphere types had a uniform, spherical structure of average diameter 3-5μm. The amount of taxol embedded in PCL microspheres was determined by HPLC and (1)H NMR to be 8-12μg per 1.0mg of PCL (loading capacity (LC): 0.8-1.2%; entrapment efficiency (EE): 16-24%). An in vitro HPLC release assay showed sustain release of taxol without an initial burst over 60days at an average rate of 0.003-0.0073mg per day. The viability patterns of human breast cancer cells (MCF-7) for PCTx-1 and -2 showed dose-dependent inhibitory effects. In the presence of PCTx-1 and -2, the MCF-7 cells showed high viability in the concentration level of, respectably, <70 and <5μg/mL.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  A sustained drug delivery system; One-pot mass production; Room temperature ionic liquids; Taxol-loaded PCL microspheres

Mesh:

Substances:

Year:  2014        PMID: 25527087     DOI: 10.1016/j.jcis.2014.11.044

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  4 in total

1.  A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment.

Authors:  Xun Yuan; Wenxiang Ji; Si Chen; Yuling Bao; Songwei Tan; Shun Lu; Kongming Wu; Qian Chu
Journal:  Int J Nanomedicine       Date:  2016-05-25

Review 2.  A review on current nanomaterials and their drug conjugate for targeted breast cancer treatment.

Authors:  Joanna Jinling Lee; Latifah Saiful Yazan; Che Azurahanim Che Abdullah
Journal:  Int J Nanomedicine       Date:  2017-03-27

Review 3.  Nanomedicine applications in the treatment of breast cancer: current state of the art.

Authors:  Di Wu; Mengjie Si; Hui-Yi Xue; Ho-Lun Wong
Journal:  Int J Nanomedicine       Date:  2017-08-16

4.  Facile production of nanocomposites of carbon nanotubes and polycaprolactone with high aspect ratios with potential applications in drug delivery.

Authors:  Edyta Niezabitowska; Jessica Smith; Mark R Prestly; Riaz Akhtar; Felix W von Aulock; Yan Lavallée; Hanene Ali-Boucetta; Tom O McDonald
Journal:  RSC Adv       Date:  2018-05-04       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.